Skip to main content
Log in

Extended spectrum β-lactamase reactions inStenotrophomonas maltophilia

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bush, K.: Is it important to identify extended-spectrum β-lactamase-producing isolates? Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 361–364.

    Article  PubMed  CAS  Google Scholar 

  2. Philippon, A., Fournier, G., Paul, G., Vedel, G., Nevot, P.: Détection et distribution des β-lactamases à spectre élargi chez les entérobactéries. Méd. Malad. Infect. 12 (1988) 869–876.

    Article  Google Scholar 

  3. Vedel, G., Peyret, M. Gayral, J. P., Millot, P.: Evaluation of an expert system linked to a rapid antibiotic susceptibility testing system for the detection of β-lactam resistance phenotypes. Res. Microbiol. 147 (1996) 297–309.

    Article  PubMed  CAS  Google Scholar 

  4. Martino, R., Martínez, C., Pericas, R., Salazar, R., Solá, C., Brunet, S., Sureda, A., Domingo-Albós, A.: Bacteremia due to glucose nonfermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 610–615.

    Article  PubMed  CAS  Google Scholar 

  5. Krĉméry, V. Jr.,Pichna, P., Oravcová, E., Lacka, J., Kukuĉková, E., Studená, M., Grausová, S., Stopková, K., Krupová, I.:Stenotrophomonas maltophilia bacteremia in cancer patients. J. Hosp. Infect. 33 (1996) 75–77.

    Article  Google Scholar 

  6. Micozzi, a., Venditti, M., Monaco, M., Friedrich, A., Tagletti, F., Santilli, S., Martino, P.: Bacteremia due toStenotrophomonas maltophilia in patients with hematologic malignancies. 37th ICAAC, Toronto 1977, abstr. J-208.

  7. Prieto, N., Alarcon, T., Lopez, S., Herrero, A., Lopezbrea, M.:In vitro susceptibility ofStenotrophomonas maltophilia to several antimicrobial agents. 37th ICAAC. Toronto 1997. abstr. E-142.

  8. Bush, K., Jacoby, G. A., Medeiros, A. A.: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39 (1995) 1211–1233.

    PubMed  CAS  Google Scholar 

  9. Dufresne, J., Vézina, G., Levesque, R.: Molecular cloning and expression of imipenem-hydrolysing β-lactamase gene fromPseudomonas maltophilia. Rev. Infect. Dis. 10 (1988) 806–816.

    PubMed  CAS  Google Scholar 

  10. Bush, K.: Mechanisms of resistance inStenotrophomonas maltophilia. 36th ICAAC. Washington D. C. 1996, abstr. S-50.

  11. Livermore, D.: Carbapenemases: the next generation of β-lactamases? ASM News 59 (1993) 129–35.

    Google Scholar 

  12. Payne, D. J., Cramp, R., Bateson, J. H., Neale, J., Knowles, D. Rapid identification of metallo- and serine β-lactamases. Antimicrob. Agents Chemother. 38 (1994) 991–996.

    PubMed  CAS  Google Scholar 

  13. Sanches, G. J. E., Lopez, V. M. L., De Castro, B. A. M., Simon, P. J. A., Gutierrez, N. G., Martin, T. L., Garcia-Rodriguez, J. A.: Aztreonam/clavulanic acid in the treatment of serious infections caused byStenotrophomonas maltophilia in neutropenic patients. J. Chemother. 9 (1997) 238–240.

    Google Scholar 

  14. Hupková, M., Blahová, J., Králiková, K., Krĉméry V.: Transferable resistance to β-lactams in a nosocomial strain ofXanthomonas maltophilia. Antimicrob. Agents Chemother. 39 (1995) 1011–1014.

    PubMed  Google Scholar 

  15. Babálová, M., Blahová, J., Leŝická-Hupková, M., Krĉméry, V., Kuboňová, K.: Transfer of ceftazidime and aztreonam resistance from nosocomial strains ofXanthomonas (Stenotrophomonas) maltophilia to a recipient strain ofPseudomonas aeruginosa ML-1008. Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 925–927.

    Article  PubMed  Google Scholar 

  16. Jarlier, V. Nicolas, M. H., Fournier, G., Philippon, A.: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents inEnterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10 (1988) 867–878.

    PubMed  CAS  Google Scholar 

  17. Philippon, A., Arlet, G., Lagrange, P. H.: Origin and impact of plasmid-mediated extended-spectrum β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13 (1994) 17–29.

    Article  Google Scholar 

  18. Hupková, M., Blahová, J., Babálová, M., Krĉméry, V., Králiková, K. Transferable resistance of cefotaxime in nosocomialKlebsiella pneumoniae andEscherichia coli strains due to their production of extended-spectrum β-lactamase in Slovakia. J. Chemother. 7 (1995) 16–20.

    PubMed  Google Scholar 

  19. Vartivarian, S., Anaissie, E., Bodey, G., Sprigg, H., Rolston, H.: A changing pattern of susceptibility ofXanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38 (1994) 624–627.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blahová, J., Hupková-Leŝická, M., Králiková, K. et al. Extended spectrum β-lactamase reactions inStenotrophomonas maltophilia . Infection 26, 187–188 (1998). https://doi.org/10.1007/BF02771852

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02771852

Keywords

Navigation